- Home
- / Arcutis Biotherapeutics
Arcutis Biotherapeutics
Stock Price
$8.6
2024-10-29
Market Capitalization
$1 B
2024-10-29
Revenue
$376.1 M
FY, 2025
Arcutis Biotherapeutics Summary
Company Summary
- Overview
- Arcutis Biotherapeutics is a pharmaceutical company. It is focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology.
- Type
- Public
- Status
- Active
- Founded
- 2016
- HQ
- Westlake Village, CA, US | view all locations
- Website
- https://arcutis.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
David Osborne, Chief Technical Officer
Courtney Barton, Vice President, Chief Compliance Officer, Chief of Staff
Scott Burrows, Chief Financial Officer
Operating MetricsView all
Product Candidates
4
FY, 2019
Patents (US)
5
FY, 2019
Patents (Foreign)
2
FY, 2019
LocationsView all
1 location detected
Westlake Village, CA HQ
United States
2945 Townsgate Rd #110
Arcutis Biotherapeutics Financials
Summary Financials
- Revenue (Q1, 2026)
- $105.4M
- Gross profit (Q1, 2026)
- $95.6M
- Net income (Q1, 2026)
- ($11.3M)
- Cash (Q1, 2026)
- $34.8M
- EBIT (Q1, 2026)
- ($9.1M)
- Enterprise value
- $1.1B